Logo image of PPBT

PURPLE BIOTECH LTD-ADR (PPBT) Stock Price, Quote, News and Overview

NASDAQ:PPBT - Nasdaq - US74638P1093 - ADR - Currency: USD

2.6  +0.21 (+8.79%)

After market: 2.66 +0.06 (+2.31%)

PPBT Quote, Performance and Key Statistics

PURPLE BIOTECH LTD-ADR

NASDAQ:PPBT (5/30/2025, 8:27:10 PM)

After market: 2.66 +0.06 (+2.31%)

2.6

+0.21 (+8.79%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High16.8
52 Week Low2
Market Cap6.89M
Shares2.65M
Float2.64M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-14 2025-08-14
IPO09-03 1978-09-03


PPBT short term performance overview.The bars show the price performance of PPBT in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 -20

PPBT long term performance overview.The bars show the price performance of PPBT in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of PPBT is 2.6 USD. In the past month the price increased by 10.64%. In the past year, price decreased by -83.9%.

PURPLE BIOTECH LTD-ADR / PPBT Daily stock chart

PPBT Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 53.61 699.12B
JNJ JOHNSON & JOHNSON 15.44 373.45B
NVO NOVO-NORDISK A/S-SPONS ADR 20.08 317.70B
NVS NOVARTIS AG-SPONSORED ADR 13.93 228.64B
AZN ASTRAZENECA PLC-SPONS ADR 16.55 225.80B
MRK MERCK & CO. INC. 9.86 192.95B
PFE PFIZER INC 7.32 133.55B
SNY SANOFI-ADR 11.22 120.15B
BMY BRISTOL-MYERS SQUIBB CO 6.58 98.25B
GSK GSK PLC-SPON ADR 9.26 83.26B
ZTS ZOETIS INC 28.01 75.08B
HLN HALEON PLC-ADR 23.16 51.11B

About PPBT

Company Profile

PPBT logo image Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The firm is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.

Company Info

PURPLE BIOTECH LTD-ADR

4 Oppenheimer St., Science Park

Rehovot 7670104 IL

CEO: Gil Efron

Employees: 9

PPBT Company Website

PPBT Investor Relations

Phone: 97239333121

PURPLE BIOTECH LTD-ADR / PPBT FAQ

What is the stock price of PURPLE BIOTECH LTD-ADR today?

The current stock price of PPBT is 2.6 USD. The price increased by 8.79% in the last trading session.


What is the ticker symbol for PURPLE BIOTECH LTD-ADR stock?

The exchange symbol of PURPLE BIOTECH LTD-ADR is PPBT and it is listed on the Nasdaq exchange.


On which exchange is PPBT stock listed?

PPBT stock is listed on the Nasdaq exchange.


What is PURPLE BIOTECH LTD-ADR worth?

PURPLE BIOTECH LTD-ADR (PPBT) has a market capitalization of 6.89M USD. This makes PPBT a Nano Cap stock.


How many employees does PURPLE BIOTECH LTD-ADR have?

PURPLE BIOTECH LTD-ADR (PPBT) currently has 9 employees.


What are the support and resistance levels for PURPLE BIOTECH LTD-ADR (PPBT) stock?

PURPLE BIOTECH LTD-ADR (PPBT) has a support level at 2.34 and a resistance level at 2.62. Check the full technical report for a detailed analysis of PPBT support and resistance levels.


Should I buy PURPLE BIOTECH LTD-ADR (PPBT) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does PURPLE BIOTECH LTD-ADR (PPBT) stock pay dividends?

PPBT does not pay a dividend.


When does PURPLE BIOTECH LTD-ADR (PPBT) report earnings?

PURPLE BIOTECH LTD-ADR (PPBT) will report earnings on 2025-08-14.


What is the Price/Earnings (PE) ratio of PURPLE BIOTECH LTD-ADR (PPBT)?

PURPLE BIOTECH LTD-ADR (PPBT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.67).


What is the Short Interest ratio of PURPLE BIOTECH LTD-ADR (PPBT) stock?

The outstanding short interest for PURPLE BIOTECH LTD-ADR (PPBT) is 2.48% of its float. Check the ownership tab for more information on the PPBT short interest.


PPBT Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to PPBT. When comparing the yearly performance of all stocks, PPBT is a bad performer in the overall market: 94.64% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

PPBT Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to PPBT. While PPBT seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PPBT Financial Highlights

Over the last trailing twelve months PPBT reported a non-GAAP Earnings per Share(EPS) of -3.67. The EPS increased by 71.43% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -19.55%
ROE -22.03%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%100%
Sales Q2Q%N/A
EPS 1Y (TTM)71.43%
Revenue 1Y (TTM)N/A

PPBT Ownership and Analysts


Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %2.48%
Short Ratio0.54
Analysts
Analysts0
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A